在冠状动脉疾病的表征中以PET确定心肌输液和流量
Ines Valenta1, Thomas H Schindler1
1Washington University in St. Louis School of Medicine, Mallinckrodt Institute of Radiology, Division of Nuclear Medicine, St. Louis, MO, USA.
Journal of medical imaging and radiation sciences
|February 25, 2024
概括
位子发射断层扫描 (PET) 心肌 perfusion 图像测量心肌血流量 (MBF),有助于诊断冠状动脉微血管功能障碍 (CMD) 和早期动脉样硬化. 这种先进的成像技术为心血管疾病管理提供了全面的评估.
科学领域:
- 心血管成像 - 心血管成像
- 核心脏病学 核心脏病学
- 身体生理学 身体生理学
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 是心痛的关键原因,特别是在没有阻塞性冠状动脉疾病 (CAD) 的患者中.
- 传统的心肌输液成像主要识别心上冠状动脉疾病 (CAD),往往缺少早期动脉样硬化或CMD.
- 精确,非侵入性评估心肌血流 (MBF) 对于诊断和管理各种心血管疾病至关重要.
研究的目的:
- 评估位子发射断层扫描 (PET) 的实用性,用于量化绝对心肌血流量 (MBF).
- 探索PET-MBF量化在确定冠状动脉微血管功能障碍 (CMD) 和早期动脉样硬化的作用.
- 评估PET-MBF在检测扩散性缺血和指导心血管治疗决策方面的潜力.
主要方法:
- 采用前置子发射断层扫描 (PET) 与先进的追踪器动力学建模.
- 量化区域心肌动脉血流 (MBF) 绝对值 (mL/g/min) 在休息状态和在药物诱导的高血压期间.
- 评估心肌流量储备 (MFR) 和评估压力和休息期间的左心室腔动态.
主要成果:
- 通过PET-MBF量化,可以同时评估心肌输液和绝对MBF.
- 这种方法可以识别CMD和早期动脉样硬化,扩展到传统的上心脏CAD检测之外.
- 由于其高分辨率和人工物减少,PET成像对肥胖患者和明显的乳腺组织的CAD检测具有优势.
结论:
- PET-MBF量化提供了心肌 perfusion 和流量的全面评估,对于诊断CMD和早期动脉样硬化至关重要.
- 这种技术扩大了心肌输液成像的诊断能力,为微血管功能提供了洞察力.
- 需要进一步调查,以确定PET-MBF评估是否转化为改善心血管结果并指导个性化治疗策略.
相关概念视频
Pulse
4.0K
The pulse is one of the most fundamental physiological indicators of the body's cardiovascular health. It is the rhythmic expansion and contraction of the arterial walls in response to the pressure generated by the heart's pumping action.
Pulse Rate and its Significance
Pulse rate, often measured in beats per minute (bpm), reflects the heart rate (HR), which is influenced by numerous factors such as stress, physical activity, and hormonal changes. A normal resting adult pulse rate falls...
Pulse Rate and its Significance
Pulse rate, often measured in beats per minute (bpm), reflects the heart rate (HR), which is influenced by numerous factors such as stress, physical activity, and hormonal changes. A normal resting adult pulse rate falls...
4.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
769
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Imaging Studies for Cardiovascular System V: CT
674
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
674
Acute Coronary Syndrome III: Diagnostic Studies
502
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Dysrhythmias V: Evaluating Dysrhythmias
428
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
428
Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802


